VD

Vasa Denticity Ltd

Q1 FY27Healthcare Equipment & Supplies

Vasa Denticity Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹418
Market cap₹673 Cr
P/E62.4
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

2 of 4 strong

RevenueModerate growth
MarginMargins slightly up
CapexCapex planned
FundraiseNo fundraise planned

The short version

The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations. The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.

From Vasa Denticity Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations.
  • Revenue growth targets for FY27 are around ₹500-600 crores and ₹800-1200 crores for FY28, reflecting ambitious scaling plans.
  • Growth is expected to be driven primarily by increasing average order value and repeat purchases rather than acquiring new customers.
  • There is a focus on increasing order frequency and customer wallet share through strategies like discounts on multiple items and tech solutions offering incentives.
  • New business lines like digital dentistry equipment (intraoral scanners, 3D printers) are becoming significant growth drivers.
  • Organic growth is prioritized over acquisitions currently, with inorganic opportunities considered only if organic growth plateaus.

2 more points from Vasa Denticity Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Vasa Denticity Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.
  • Expansion into digital dentistry division (intraoral scanners, milling machines, 3D printers, imaging products) is underway and is no longer an experiment, indicating ongoing strategic investment in this segment.
  • Inventory management and supply chain improvements are being made, including forward deployment and demand forecasting to reduce stockouts and improve delivery times, implying operational capital investment.
  • The company is optimizing warehousing and logistics, with initiatives like Insta Dent for same-day/next-day delivery, requiring investment in regional warehouses.

2 more points from Vasa Denticity Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1Molbio Diagnosti
Rev 2Mar 3
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vasa Denticity Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript in the provided pages does not explicitly mention current or expected orderbook or pending orders figures. However, some related insights include: - The focus is on increasing orders per customer and number of customers, with strategies planned though no definitive guidance on growth percentages yet (Page 21). - Order volumes showed growth: quarter volumes moved from 1.58 lakh & 1.82 lakh (previous year) to 1.75 lakh & 2.04 lakh recently after correction of internal errors (Page 9). - Average order value increased by about 27% largely due to higher ticket-size products; order volume growth was around 8% (Page 6).

2 more points from Vasa Denticity Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Vasa Denticity Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹72 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Avience Biomedicals Ltd (Q1 FY27)

    New manufacturing facility has capacity to support peak revenue of around ₹250–265 crore, subject to product mix and approvals. Key concall takeaways from…

  • Fischer Medical Ventures Ltd (Q1 FY27)

    The provided pages of the investor presentation do not contain any specific revenue, sales, or volume figures for the quarter, nor details on year-on-year…

  • Molbio Diagnosti (Q1 FY27)

    Capacity utilization currently at ~58% for test kits and ~42% for devices; automation capex will double revenue capacity with minimal new investment. Key…

  • QMS Medical Allied Services Ltd (Q1 FY27)

    Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vasa Denticity Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vasa Denticity Ltd Q1 FY27 results?

The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations. The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.

What is Vasa Denticity Ltd share price analysis?

Vasa Denticity Ltd currently shows a below-average growth signal. The stock trades at a P/E of 62.4 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vasa Denticity Ltd planning capital expenditure?

The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.

Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.